Estimating the avoidable burden of certain modifiable risk factors in osteoporotic hip fracture using Generalized Impact Fraction (GIF) model in Iran

Journal of Diabetes and Metabolic Disorders

Volumn 12, Issue 1, 2013, Pages

  Shahnazari, Banafsheh ^a   Keshtkar, Abbasali ^a   Soltani, Akbar ^a   Aghamaleki, Aria ^a   Mansour, Asieh ^a   Matin, Bahar ^a   Saghafi, Sharareh ^b   Dini, Mahboubeh ^c   Khashayar, Patricia ^a   Larijani, Bagher ^a,d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

BMI; Calcium; Fragility hip fracture; Incidence; Osteoporotic fracture; Physical activity; Prevalence; Smoke; Vitamin D

Indexed keywords

CALCIUM; VITAMIN D;

ARTICLE; BODY MASS; BODY WEIGHT; CALCIUM INTAKE; EXERCISE; GENERALIZED IMPACT FRACTION MODEL; HIP FRACTURE; HUMAN; IRAN; MORBIDITY; OSTEOPOROSIS; PHYSICAL ACTIVITY; PREVALENCE; RISK FACTOR; SMOKING; STATISTICAL MODEL; VITAMIN BLOOD LEVEL; VITAMIN INTAKE; CALCIUM BLOOD LEVEL; CLINICAL ASSESSMENT TOOL; FRAGILITY FRACTURE; GENERALIZED IMPACT FRACTION; META ANALYSIS (TOPIC); OSTEOPOROTIC HIP FRACTURE; RISK ASSESSMENT; RISK REDUCTION; SYSTEMATIC REVIEW (TOPIC); VITAMIN SUPPLEMENTATION;

EID: 84882767790     PISSN: None     EISSN: 22516581     Source Type: Journal    
DOI: 10.1186/2251-6581-12-10     Document Type: Article

References (36)

1. Ryan KJ, Berkowitz RS, Barbieri RL, Dunaif A. Kistner's Gynecology and women's Health 1999, 52-54. st. Louis: Published by Mosby, 7.
2. Watts NB. Focus on primary care: postmenopausal osteoporosis. Obstet Gynecol Surv 1999, 54(8):532. 10.1097/00006254-199908000-00024, 10434274.
3. Johnell O, Kanis J. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 2006, 17(12):1726-1733. 10.1007/s00198-006-0172-4, 16983459.
4. Ahlborg HG, Johnell O, Turner CH, Rannevik G, Karlsson MK. Bone loss and bone size after menopause. N Engl J Med 2003, 349(4):327-334. 10.1056/NEJMoa022464, 12878739.
5. Wainwright SA, Marshall LM, Ensrud KE, Cauley JA, Black DM, Hillier TA, et al. Hip fracture in women without osteoporosis. J Clin Endocrinol Metab 2005, 90(5):2787-2793. 10.1210/jc.2004-1568, 15728213.
6. Cooper C, Melton LJ. Epidemiology of osteoporosis. Trends in Endocrinology & Metabolism 1992, 3(6):224-229. 10.1016/1043-2760(92)90032-V, 23407904.
7. Wozney J, Rosen V. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop Relat Res 1998, 346:26-37.
8. Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporosis fractures. Lancet 2002, 359:2018-2026. 10.1016/S0140-6736(02)08827-X, 12076571.
9. Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet 2002, 359(9319):1761-1767. 10.1016/S0140-6736(02)08657-9, 12049882.
10. Wolinsky FD, Fitzgerald JF, Stump TE. The effect of hip fracture on mortality, hospitalization, and functional status: a prospective study. Am J Public Health 1997, 87(3):398-403. 10.2105/AJPH.87.3.398, 1381011, 9096540.
11. Lau E, Cooper C. The epidemiology of osteoporosis: the oriental perspective in a world context. Clin Orthop Relat Res 1996, 323:65.
12. Islam MZ, Shamim AA, Kemi V, Nevanlinna A, Akhtaruzzaman M, Laaksonen M, et al. Vitamin D deficiency and low bone status in adult female garment factory workers in Bangladesh. Br J Nutr 2008, 99:1322-1329.
13. Donaldson LJ, Cook A, Thomson RG. Incidence of fractures in a geographically defined population. Journal of epidemiology and Community Health 1990, 44(3):241-245. 10.1136/jech.44.3.241, 1060650, 2273364.
14. Reginster J, Burlet N. Osteoporosis: a still increasing prevalence. Bone 2006, 38(1):4-9. 10.1016/j.bone.2005.07.016, 16139579.
15. Aghaei Meybodi H, Khashayar P, Heshmat R, Rezaei Homami M, Larijani B. The prevalence of osteoporosis in an Iranian Population [Unpublished Data] [IOF]. J Clin Densitom 2010, 112:1-13.
16. Salehi I, Khazaeli S, Najafizadeh SR, Ashraf H, Malekpour M. High prevalence of low bone density in young Iranian healthy individuals. Clin Rheumatol 2009, 28(2):173-177. 10.1007/s10067-008-1008-8, 18810571.
17. Larijani B, Resch H, Bonjour J, Meybodi HRA, Tehrani MRM. Osteoporosis in Iran, overview and management 2007, 1-13. Iranian Journal of Public Health: A supplementary issue on Osteoporosis.
18. Zolfaghari M, Taghizadeh Z, Maghbouli Z, Keshtkar AA, Kazemnezhad A, Larijani B. The incidence of osteoporotic hip fracture in 3 years fallow up of Iranian Multicenter Osteoporosis Study (IMOS). Journal of Reproduction and Infertility 2005, 6(1):37-42.
19. Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002, 359(9321):1929-1936. 10.1016/S0140-6736(02)08761-5, 12057569.
20. Morgenstern H, Bursic ES. A method for using epidemiologic data to estimate the potential impact of an intervention on the health status of a target population. J Community Health 1982, 7(4):292-309. 10.1007/BF01318961, 7130448.
21. Drescher K, Becher H. Estimating the generalized impact fraction from case-control data. Biometrics. 1997 Sep, 53(3):1170-1176.
22. Tang BMP, Eslick GD, Nowson C, Smith C, Bensoussan A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 2007, 370(9588):657-666. 10.1016/S0140-6736(07)61342-7, 17720017.
23. Lai JKC, Lucas RM, Clements MS, Roddam AW, Banks E. Hip fracture risk in relation to vitamin D supplementation and serum 25-hydroxyvitamin D levels: a systematic review and meta-analysis of randomized controlled trials and observational studies. BMC Publ Health 2010, 10:331-348.
24. Law MR, Hackshaw AK. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ 1997, 315(7112):841-846. 10.1136/bmj.315.7112.841, 2127590, 9353503.
25. Feskanich D, Willett W, Colditz G. Walking and leisure-time activity and risk of hip fracture in postmenopausal women. JAMA: the journal of the American Medical Association 2002, 288(18):2300-2306.
26. Høidrup S, Prescott E, Sørensen TIA, Gottschau A, Lauritzen JB, Schroll M, et al. Tobacco smoking and risk of hip fracture in men and women. International journal of epidemiology 2000, 29(2):253-259. 10.1093/ije/29.2.253, 10817121.
27. Najmabadi S, Nojomi M. Nutritional supplement use among adults in different areas of West Tehran. Iranian Journal of Endocrinology and Metabolism 2010, 12(4):365-375.
28. Heshmat R, et al. Vitamin D deficiency in Iran: A multi- centre study among different urban areas. Health, 2008, A supplementary issue on Osteoporosis and B. Iranian J public health 2008, (1):72-78.
29. Emami H, Habbibian S, Salehi P, Azizi F. Pattern and smoking habit in an urban area in Tehran. Glucose and Lipid Study. Pejouhesh dar Pezeshki 2001, 27:47-52.
30. Islami F, et al. Epidemiologic feature of a cohort study in upper GI cancers in west of Golestan province. Br J Cancer 2004, 90(7):1402-1406. 10.1038/sj.bjc.6601737, 2409685, 15054463.
31. Momenan A, Delshad M, Mirmiran P, Ghanbarian A, Safarkhani M, Azizi F. Physical inactivity and related factors in an adult Tehranian population (Tehran lipid and glucose study). Iranian Journal of Endocrinology and Metabolism 2012, 13(5):493-503.
32. Laet C, Kanis J, Odén A, Johanson H, Johnell O, Delmas P, et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 2005, 16(11):1330-1338. 10.1007/s00198-005-1863-y, 15928804.
33. Loehr LR, Rosamond WD, Poole C, McNeill AM, Chang PP, Deswal A, et al. The potentially modifiable burden of incident heart failure Due to obesity the atherosclerosis risk in communities study. Am J Epidemiol 2010, 172(7):781-789. 10.1093/aje/kwq213, 3025653, 20716703.
34. Nedjat S, Feizzadeh A, Asgharie S, Keshtkar A, Heshmat R, Majdzadeh S. HIV risk factors in iran; systematic review, meta-analyses and GIF approaches. Health Monitor (Payesh) 2007, 6(1):45-54.
35. Hamidi Z, Majdzadeh R, Soltani A, Larijani B. Causal the composition of risk factors in osteoporosis burden. Journal of medical council of IRI 2007, 24(4):381-392.
36. Bischoff-ferrari H, et al. A pooled analysis of vitamin D dose requirements for fracture prevention. NEJM 2012, 367(1):40-49. 10.1056/NEJMoa1109617, 22762317.